Mometasone Furoate Ointment
Product Images NDC 51672-1311

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mometasone Furoate (NDC 51672-1311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mometasone 01)

FDA Label Image

Principal Display Panel (45 g Tube Label)

Principal Display Panel (45 g Tube Label)
This is a medication with the National Drug Code 51672-1311-6 that contains 1 mg of mometasone furoate in an ointment base of hexylene glycol, propylene glycol stearate, white petrolatum and white wax. It is for dermatologic use only and should not be used in eyes. This medication is available for prescription only and the package insert should be read for full prescribing information. It should be stored at a temperature of 20°C-25°C (68°F-77°F) and the pointed end of the cap should be used to puncture the seal. The tube has information like lot number and expiry date on the crimp. The manufacturer of this medication is Taro Pharmaceuticals Inc. and it is distributed in the US by Taro Pharmaceuticals U.S.A., Inc. The location of the manufacturer is Brampton, Ontario, Canada L6T 1C1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.